当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析 - 现金流量表

回盛生物

(300871)

  

流通市值:52.79亿  总市值:52.79亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金345,560,420.551,308,078,441.82946,899,543.93639,310,182.87
  收到的税费返还982,083.4210,765,600.178,262,739.38,262,739.3
  收到其他与经营活动有关的现金23,831,109.0783,790,485.336,422,655.317,770,597.13
  经营活动现金流入小计370,373,613.041,402,634,527.29991,584,938.53665,343,519.3
  购买商品、接受劳务支付的现金195,358,121.66777,275,720.96574,022,892.15393,921,808.8
  支付给职工以及为职工支付的现金54,610,564.16149,028,972.3110,923,067.2975,869,225.3
  支付的各项税费26,927,525.684,533,881.355,831,743.930,343,922.05
  支付其他与经营活动有关的现金40,857,102.92153,347,555.7369,292,174.4441,355,837.56
  经营活动现金流出小计317,753,314.341,164,186,130.29810,069,877.78541,490,793.71
  经营活动产生的现金流量净额52,620,298.7238,448,397181,515,060.75123,852,725.59
二、投资活动产生的现金流量:
  收回投资收到的现金132,961,200649,606,605.64489,274,905.64273,934,405.64
  取得投资收益收到的现金1,401,730.487,100,045.125,040,367.333,637,846.49
  处置固定资产、无形资产和其他长期资产收回的现金净额-397,577.82380,000380,000
  处置子公司及其他营业单位收到的现金净额-71,257.46---
  投资活动现金流入小计134,291,673.02657,104,228.58494,695,272.97277,952,252.13
  购建固定资产、无形资产和其他长期资产支付的现金70,847,142.9496,919,488.270,454,855.7751,722,454.43
  投资支付的现金192,519,400615,025,416.26568,190,500345,450,000
  取得子公司及其他营业单位支付的现金--1,146,800.35-
  投资活动现金流出小计263,366,542.94711,944,904.46639,792,156.12397,172,454.43
  投资活动产生的现金流量净额-129,074,869.92-54,840,675.88-145,096,883.15-119,220,202.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金-375,0003,106,705.85-
  其中:子公司吸收少数股东投资收到的现金-375,0003,106,705.85-
  取得借款收到的现金199,950,000220,000,000190,000,000180,000,000
  收到其他与筹资活动有关的现金12,680,10238,449,13234,251,98423,658,178
  筹资活动现金流入小计212,630,102258,824,132227,358,689.85203,658,178
  偿还债务支付的现金94,000,000368,075,007.66246,074,853.92214,074,853.92
  分配股利、利润或偿付利息支付的现金1,459,849.9749,919,954.4648,388,903.1625,965,207.35
  支付其他与筹资活动有关的现金67,2001,067,928.3947,600354,500
  筹资活动现金流出小计95,527,049.97419,062,890.42295,411,357.08240,394,561.27
  筹资活动产生的现金流量净额117,103,052.03-160,238,758.42-68,052,667.23-36,736,383.27
四、汇率变动对现金及现金等价物的影响-881,004.09-1,837,642.35-130,204.92108,497.32
五、现金及现金等价物净增加额39,767,476.7221,531,320.35-31,764,694.55-31,995,362.66
  加:期初现金及现金等价物余额206,123,263.59184,591,943.24184,591,943.24184,591,943.24
  期末现金及现金等价物余额245,890,740.31206,123,263.59152,827,248.69152,596,580.58
补充资料:
  净利润-253,488,650.71-117,545,832.95
  资产减值准备-8,949,906.1-2,142,279.23
  固定资产和投资性房地产折旧-116,997,069.72-57,390,335.2
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-116,997,069.72-57,390,335.2
  无形资产摊销-3,368,021.54-1,688,957.46
  长期待摊费用摊销-952,845.13-291,280.01
  固定资产报废损失-614,061.75-21,157.69
  公允价值变动损失--1,204,788.1--7,488,537.35
  财务费用-15,972,262.68-11,383,103.99
  投资损失--8,886,087.59--3,616,674.49
  递延所得税--4,290,088.64-2,447,778.39
  其中:递延所得税资产减少-1,883,107.58-6,099,537.92
    递延所得税负债增加--6,173,196.22--3,651,759.53
  存货的减少--22,942,933.64-1,018,015.3
  经营性应收项目的减少--43,451,396.91-14,177,420.75
  经营性应付项目的增加--83,730,639.73--70,438,111.79
  其他-2,611,513.98--2,710,111.75
  现金的期末余额-206,123,263.59-152,596,580.58
  减:现金的期初余额-184,591,943.24-184,591,943.24
  现金及现金等价物的净增加额-21,531,320.35--31,995,362.66
公告日期2026-04-282026-04-172025-10-282025-08-06
审计意见(境内)标准无保留意见
TOP↑